The ACACB gene rs2268388 polymorphism is associated with nephropathy in Caucasian patients with diabetes: a meta-analysis

Ren Fail. 2015 Jul;37(6):925-8. doi: 10.3109/0886022X.2015.1052978. Epub 2015 Jun 1.

Abstract

To date, case-control studies on the association between a single-nucleotide polymorphism (SNP), rs2268388, in the acetyl-coenzyme A carboxylase beta (ACACB) gene and diabetic nephropathy have provided controversial results. To clarify the effect of rs2268388 on the risk of diabetic nephropathy, a meta-analysis of all case-control studies was performed. The fixed effects and random effects models showed that the C allele was associated with a decreased susceptibility risk of diabetic nephropathy compared with the T allele among Caucasian patients with diabetes. The contrast of the recessive model produced the same pattern of results as the allele contrast. Our pooled data suggest a significant association exists between rs2268388 and diabetic nephropathy among Caucasian patients with diabetes.

Keywords: ACACB; diabetic nephropathy; meta-analysis; polymorphism; susceptibility.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Acetyl-CoA Carboxylase / genetics*
  • Alleles
  • Case-Control Studies
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetic Nephropathies / ethnology
  • Diabetic Nephropathies / genetics*
  • Diabetic Nephropathies / physiopathology
  • Female
  • Genetic Predisposition to Disease / ethnology*
  • Humans
  • Incidence
  • Male
  • Polymorphism, Single Nucleotide*
  • Prognosis
  • Risk Assessment
  • White People / genetics

Substances

  • ACACB protein, human
  • Acetyl-CoA Carboxylase